243 related articles for article (PubMed ID: 10417495)
1. The effects of moclobemide on the pharmacokinetics of the 5-HT1B/1D agonist rizatriptan in healthy volunteers.
Van Haarst AD; Van Gerven JM; Cohen AF; De Smet M; Sterrett A; Birk KL; Fisher AL; De Puy ME; Goldberg MR; Musson DG
Br J Clin Pharmacol; 1999 Aug; 48(2):190-6. PubMed ID: 10417495
[TBL] [Abstract][Full Text] [Related]
2. Influence of beta-adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5-HT1B/1D agonist: differential effects of propranolol, nadolol and metoprolol.
Goldberg MR; Sciberras D; De Smet M; Lowry R; Tomasko L; Lee Y; Olah TV; Zhao J; Vyas KP; Halpin R; Kari PH; James I
Br J Clin Pharmacol; 2001 Jul; 52(1):69-76. PubMed ID: 11453892
[TBL] [Abstract][Full Text] [Related]
3. Rizatriptan, a novel 5-HT1B/1D agonist for migraine: single- and multiple-dose tolerability and pharmacokinetics in healthy subjects.
Goldberg MR; Lee Y; Vyas KP; Slaughter DE; Panebianco D; Ermlich SJ; Shadle CR; Brucker MJ; McLoughlin DA; Olah TV
J Clin Pharmacol; 2000 Jan; 40(1):74-83. PubMed ID: 10631625
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects.
Berlin I; Zimmer R; Thiede HM; Payan C; Hergueta T; Robin L; Puech AJ
Br J Clin Pharmacol; 1990 Dec; 30(6):805-16. PubMed ID: 1705137
[TBL] [Abstract][Full Text] [Related]
5. Migraine pharmacotherapy with oral triptans: a rational approach to clinical management.
Millson DS; Tepper SJ; Rapoport AM
Expert Opin Pharmacother; 2000 Mar; 1(3):391-404. PubMed ID: 11249525
[TBL] [Abstract][Full Text] [Related]
6. CNS effects of sumatriptan and rizatriptan in healthy female volunteers.
van der Post J; Schram MT; Schoemaker RC; Pieters MS; Fuseau E; Pereira A; Baggen S; Cohen AF; van Gerven JM
Cephalalgia; 2002 May; 22(4):271-81. PubMed ID: 12100089
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of monoamine oxidase by moclobemide: effects on monoamine metabolism and secretion of anterior pituitary hormones and cortisol in healthy volunteers.
Koulu M; Scheinin M; Kaarttinen A; Kallio J; Pyykkö K; Vuorinen J; Zimmer RH
Br J Clin Pharmacol; 1989 Feb; 27(2):243-55. PubMed ID: 2469451
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, placebo-controlled evaluation of the effect of oral doses of rizatriptan 10 mg on oral contraceptive pharmacokinetics in healthy female volunteers.
Shadle CR; Liu G; Goldberg MR
J Clin Pharmacol; 2000 Mar; 40(3):309-15. PubMed ID: 10709161
[TBL] [Abstract][Full Text] [Related]
9. Comparative investigation of the effect of moclobemide and toloxatone on monoamine oxidase activity and psychometric performance in healthy subjects.
Dingemanse J; Berlin I; Payan C; Thiede HM; Puech AJ
Psychopharmacology (Berl); 1992; 106 Suppl():S68-70. PubMed ID: 1546145
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous inhibition of catechol-O-methyltransferase and monoamine oxidase A: effects on hemodynamics and catecholamine metabolism in healthy volunteers.
Illi A; Sundberg S; Ojala-Karlsson P; Scheinin M; Gordin A
Clin Pharmacol Ther; 1996 Apr; 59(4):450-7. PubMed ID: 8612391
[TBL] [Abstract][Full Text] [Related]
11. Effect of MAO-A inhibition on the pharmacokinetics of almotriptan, an antimigraine agent in humans.
Fleishaker JC; Ryan KK; Jansat JM; Carel BJ; Bell DJ; Burke MT; Azie NE
Br J Clin Pharmacol; 2001 May; 51(5):437-41. PubMed ID: 11422001
[TBL] [Abstract][Full Text] [Related]
12. Lack of pharmacokinetic and pharmacodynamic interaction between rizatriptan and paroxetine.
Goldberg MR; Lowry RC; Musson DG; Birk KL; Fisher A; De Puy ME; Shadle CR
J Clin Pharmacol; 1999 Feb; 39(2):192-9. PubMed ID: 11563413
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic-pharmacodynamic interactions between two selective monoamine oxidase inhibitors: moclobemide and selegiline.
Dingemanse J; Kneer J; Wallnöfer A; Kettler R; Zürcher G; Koulu M; Korn A
Clin Neuropharmacol; 1996 Oct; 19(5):399-414. PubMed ID: 8889283
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological analysis of the haemodynamic effects of 5-HT1B/D receptor agonists in the normotensive rat.
Pagniez F; Valentin JP; Vieu S; Colpaert FC; John GW
Br J Pharmacol; 1998 Jan; 123(2):205-14. PubMed ID: 9489607
[TBL] [Abstract][Full Text] [Related]
15. Initial human experience with MK-462 (rizatriptan): a novel 5-HT1D agonist.
Sciberras DG; Polvino WJ; Gertz BJ; Cheng H; Stepanavage M; Wittreich J; Olah T; Edwards M; Mant T
Br J Clin Pharmacol; 1997 Jan; 43(1):49-54. PubMed ID: 9056052
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of moclobemide and selegiline on tyramine-evoked mydriasis in man.
Bitsios P; Langley RW; Tavernor S; Pyykkö K; Scheinin M; Szabadi E; Bradshaw CM
Br J Clin Pharmacol; 1998 Jun; 45(6):551-8. PubMed ID: 9663810
[TBL] [Abstract][Full Text] [Related]
17. Evidence that the reversible MAO-A inhibitor moclobemide increases prolactin secretion by a serotonergic mechanism in healthy male volunteers.
Scheinin M; Koulu M; Karhuvaara S; Zimmer RH
Life Sci; 1990; 47(16):1491-9. PubMed ID: 2250565
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of oral moclobemide in healthy human subjects and effects on MAO-activity in platelets and excretion of urine monoamine metabolites.
Wiesel FA; Raaflaub J; Kettler R
Eur J Clin Pharmacol; 1985; 28(1):89-95. PubMed ID: 3987791
[TBL] [Abstract][Full Text] [Related]
19. Zolmitriptan-induced growth hormone release in humans: mediation by 5-HT1D receptors?
Whale R; Bhagwagar Z; Cowen PJ
Psychopharmacology (Berl); 1999 Jul; 145(2):223-6. PubMed ID: 10463324
[TBL] [Abstract][Full Text] [Related]
20. Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents.
Deleu D; Hanssens Y
Acta Neurol Belg; 1999 Jun; 99(2):85-95. PubMed ID: 10427351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
